Einstein the Second
28 Sep 2015
Re: 550 support? Looks like it has found support just above 600 p twice in last year. It is 3rd quarter earnings season soon and some decent results from BIIB,GILD etc could help it put in a bottom.
stressboy
28 Sep 2015
550 support? Looking on the 5 year chart there is support at 550 (roughly, looking at the chart on my phone is never great!). Will it drop that far? Who knows, just saying that purely on charting 550 COULD be the bottom.
Dragons teeth
17 Aug 2015
Re: Woodford Some biotechs in bubble Well that was 4 months old when you posted it and he's loaded his Patient Capital IT with Biotech companies to the extent that I'm thinking I'm overloaded in the Biotech sector , something gas to go.
Kingel
05 Aug 2015
Woodford Some biotechs in bubble Video[link]
Einstein the Second
27 Jul 2015
Re: oh dear ! Oh dear has it. Be interesting to see how much the discount has widened, it is more than just a lower NAV.
valeite
26 Jul 2015
Re: oh dear ! smart r's.....we'll see !
Sandy Hunter
25 Jul 2015
Re: oh dear ! You're right, oh dear!Oh dear that you didn't notice that most of the fall happened before the London market closed on Friday. Have a look at Biogen's sp fall over Thursday nightHope you haven't put in a sell order on the back of your Oh Dear for Monday morning
valeite
24 Jul 2015
oh dear ! biggest holding biogen down 22.1% today which means bad news for Monday
bradders64
22 Jul 2015
Re: Biotech scales new heights 30-50% change certainly wont happen overnight. I set a position stop loss at 15% off current price and consistanly up it as the share rises, maximum drop then of 15%. Not suggesting you do the same just sharing my approach. For what its worth i still see plenty of growth potential and i'm adding monthly at the moment.
Willow67
21 Jul 2015
Re: Biotech scales new heights When to sell, when to sell? Frankly I have no idea. This party will continue until the day it just doesn't anymore then i would imagine there will be a 30-50% retrenchment which none of us will want to be on board for. Anyone have anything intelligent to put forward as an argument for staying in (or getting out now for that matter)!??
Kingel
19 Jul 2015
Biotech scales new heights Biotech scales new heightsMeanwhile, the astonishing run of biotechnology investment trusts gathered strength this week, as heightened mergers and acquisition activity helped companies in the sector scale the next leg of its multi-year bull run.While there have been jitters on the way, biotech stocks, and the trusts that invest in them, look set to notch up their fourth successive year of standout gains.The five-year share price returns of the three pure biotech investment trusts are staggering: BB Biotech (BION.S) is up 551.6%, Biotech Growth (BIOG + ) has grown 488.1% and International Biotechnology (IBT + ) has risen 320%.This week, they were again among the top performing investment trust shares. BB Biotech of Switzerland jumped 10.1% while UK-listed Biotech Growth and Worldwide Healthcare (WWH + ), both run by OrbiMed Advisers in the US, rose 6.3% and 5.8% respectively.The sector has consistently confounded those who argue biotech stocks have risen too far. Each time the sector has suffered a setback, such as in April last year and July, when US Federal Reserve chair Janet Yellen argued valuations had become ‘stretched’, it has come back stronger.Buyouts are helping biotech stocks hit new heights this year. Reuters estimates that around €250 billion (£160 billion) of deals have been completed in the healthcare sector in 2015, with US group Celgene’s (CELG.O) $7.2 billion takeover of peer Receptos (RCPT.O) the latest.Shares in Receptos jumped 11% in Wednesday’s trading, providing a particular boost for BB Biotech, which is the company’s third largest fund shareholder. Biotech Growth has a smaller stake, while all three trusts are invested in Celgene, whose shares also rose, up 7% on the news.When Biotech Growth last month celebrated its 10th birthday OrbiMed didn't betray any nervousness over the lofty levels of biotech stocks. Fund manager Sven Borho said earnings growth was spurring share price gains, rather than a bubble forming around the sector. ‘Biotech has seen four years of consistent outperformance versus [the S&P 500] and this has largely been driven by earnings and sales growth in the industry,’ he said.‘We are very optimistic and we believe investment opportunities and valuation in biotech are here to set the stage for the next 10 years.’[link]
Rusty Jock
09 May 2015
Re: Last spring With respect , the election result had little effect on the BIOG share price on Friday . BIOG share price was flat all morning while election sensitive stocks jumped from the off . It only started rising a bit from mid-day , with the major upturn from mid afternoon as the Nasdaq Biotech index opened with a jump .The NBI Index is now 4% off its recent top while BIOG is still about 9% down on its recent peak , so maybe it has a bit of catch up still to do . Who knows .... its not an index tracker , but it does follow NBI trends .Maybe the solid employment figs from the USA on Friday may help to nudge US markets higher after recent falls , and maybe the Biotech sector will stabilise after the recent shake-out .I am certainly looking for Biotechs to retest recent highs after the healthy correction of 9-10% in the last 2-3 weeks , and resume the long term uptrend .I have tracked BIOG and compared it with all the other ITs , funds , ETFs and my analysis virtually always shows BIOG at the top of the performance metrics . Every now and then an IBT, BB Biotech or Framlington option may match or exceed its performance , but the consistent outperformer over several years is BIOG . It is also probably the most volatile . But if you believe in the long term Biotech story , BIOG is a decent long term buy and hold , provided you can learn to switch off when the tree shakes and asset prices fall temporarily .So I have a large amount invested in BIOG as a long term core holding which I have learned to hold . On big pullbacks I also buy it in my trading account and am currently bought for a trade at 755p , looking for a quick profit at 800p + .It works for me .
stressboy
08 May 2015
Re: Last spring Yep, I agree todays rise is off the back of the election. The direction of Biotech remains questionable,Cheers Sage for the comments.
sage in the hills
08 May 2015
Re: Last spring StressboyThe week finishes with a 5% post election relief gain.The question still continues re sustainable support as others have outlined here.SAGE
holland44
08 May 2015
Re: Last spring I use III too. For Intermediate KST, click Analysis > Technical Insight on BIOG's homepage, and under the list of Events, click on Intermediate KST which last occurred on 6 March 2015. This takes you to a page of chart sections with Intermediate KST at the top, together with Price and Volume by default; you can also select chart sections for other signals like MACD using the "Add Chart Section" on the right hand side.It is possible to set a new default set of Chart Sections, so you see them every time you view a share, but I've forgotten how to do this!
